Unlike other weight loss solutions, Wegovy addresses the biological factors that make weight loss challenging, helping users feel fuller for longer and reducing cravings
federal research data in which people were asked about their GLP-1 prescriptions.Results showed that among people without diabetes, GLP-1 drug use rose from 0.1% of the population in 2018 to 0.4% in 2022.That doesnt seem like a lot, amounting to an estimated 854,000 Americans without diabetes using GLP-1 drugs to lose weight in 2022, but the drugs are costly, and can run close to $1,000 or more a month, researchers found.As a result, estimated annual spending on GLP-1 drugs among non-diabetics rose from $1.6 billion between 2018 and 2021 to $5.8 billion in 2022, the study showed.On average, the drugs cost $1,540 per prescription, but patients paid an average of just under $35 out-of-pocket for each prescription.The study provides the first characterization of nationwide GLP-1 use and spending among individuals without diabetes to guide ongoing debates about balancing the sustainability of health care spending against improving accessibility and affordability of GLP-1 medications going forward, researchers concluded.More informationHarvard Medical School has more on insurance coverage for GLP-1 drugs.SOURCE: Annals of Internal Medicine, March 31, 2025 .What This Means For YouPeople who are obese should talk to their doctor about whether they qualify for insurance coverage for a GLP-1 drug..Sign up for our weekly HealthDay newsletter
At the 48-week mark, the group receiving the highest dose of 24mg showed an average weight loss of 22.5% compared to placebo
Newcrom R1 is a special reverse-phase column with low silanol activity
Few supplements and herbs have been subjected to rigorous scientific trials to determine their efficacy
Diabetes Obes Metab 18(6):581589 Thalmann S, Meier CA (2007) Local adipose tissue depots as cardiovascular risk factors
